Hyperthermia in a Teenager: Is it Just a Heat Stroke?
DOI:
https://doi.org/10.20344/amp.24465Keywords:
Adolescent, Heat Stroke, Hyperthermia/etiology, Neuroleptic Malignant SyndromeAbstract
An adolescent male with obesity and autism spectrum disorder presented to the emergency department with acute confusion, chills, muscle rigidity, and severe hyperthermia (tympanic temperature 41.9ºC) after physical exertion in extreme heat. His regular medication included antipsychotics. Laboratory evaluation showed multiorgan dysfunction, supporting a diagnosis of heat stroke with concurrent neuroleptic malignant syndrome. Prompt resuscitation and external cooling were initiated, and the patient was admitted to the pediatric intensive care unit. Management included discontinuation of antipsychotics, dantrolene and bromocriptine, active temperature control using Criticool®, benzodiazepines, and aggressive intravenous fluid therapy. The patient improved gradually and was discharged after four days in intensive care and 14 days in the ward, on aripiprazole and clonidine. This case highlights the diagnostic and therapeutic challenges posed by severe hyperthermia with overlapping features of heat stroke and neuroleptic malignant syndrome.
Downloads
References
Hadad E, Cohen-Sivan Y, Heled Y, Epstein Y. Clinical review: treatment of heat stroke: should dantrolene be considered. Crit Care. 2004;9:86. DOI: https://doi.org/10.1186/cc2923
Bouchama A, Knochel J. Heat stroke. N Engl J Med. 2002;346:1978-88. DOI: https://doi.org/10.1056/NEJMra011089
Wu X, Brady J, Rosenberg H, Li G. Emergency department visits for heat stroke in the United States, 2009 and 2010. Inj Epidemiol. 2014;1:8. DOI: https://doi.org/10.1186/2197-1714-1-8
Mangus C, Canares T. Heat-related illness in children in an era of extreme temperatures. Pediatr Rev. 2019;40:97-109. DOI: https://doi.org/10.1542/pir.2017-0322
Hifumi T, Kondo Y, Shimizu K, Miyake Y. Heat stroke. J Intensive Care. 2018;6:30. DOI: https://doi.org/10.1186/s40560-018-0298-4
Sorensen C, Hess J. Treatment and prevention of heat-related illness. N Engl J Med. 2022;387:1404-13. DOI: https://doi.org/10.1056/NEJMcp2210623
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Publishing; 2013. p. 709-11. DOI: https://doi.org/10.1176/appi.books.9780890425596
Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist. 2011;1:41-7. DOI: https://doi.org/10.1177/1941875210386491
Van Rensburg R, Decloedt EH. An approach to the pharmacotherapy of neuroleptic malignant syndrome. Psychopharmacol Bull. 2019;49:84-91. DOI: https://doi.org/10.64719/pb.4581
Chun T, Mace S, Katz E. Evaluation and management of children with acute mental health or behavioral problems. Part II: recognition of clinically challenging mental health-related conditions presenting with medical or uncertain symptoms. Pediatrics. 2016;138:e20161573. DOI: https://doi.org/10.1542/9781610020862-part04-symptoms
Ananth J, Aduri K, Parameswaran S, Gunatilake S. Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment. Acta Neuropsychiatr. 2004;16:219-28. DOI: https://doi.org/10.1111/j.0924-2708.2004.00085.x
Simon LV, Hashmi MF, Callahan AL. Neuroleptic malignant syndrome. In: StatPearls. Treasure Island: StatPearls Publishing; 2023.
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-20. DOI: https://doi.org/10.1056/NEJMra041867
Jardine D. Heat illness and heat stroke. Pediatr Rev. 2007;28:249-58. DOI: https://doi.org/10.1542/pir.28.7.249
Velosa A, Neves A, Barahona-Corrêa JB, Oliveira-Maia AJ. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach. BMJ Case Rep. 2019;12:e225840. DOI: https://doi.org/10.1136/bcr-2018-225840
Wasserman DD, Kathard R, Healy M. Cooling techniques for hyperthermia. In: StatPearls. Treasure Island: StatPearls Publishing; 2026.
Wadoo O, Shah AJ, Abdelghani S. Neuroleptic malignant syndrome: a guide for psychiatrists. B J Psych Adv. 2021;27:364-73. DOI: https://doi.org/10.1192/bja.2020.71
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
